Complete Semi-Solid Manufacturing Plants: The Universal Production Plants For Creams, Ointments, Lotions & Liquids

Our unique and advanced homogenizing and emulsifying system is widely applicable across different industries, especially in the production of ointment creams, lotions, and suspensions. We designed our system to cater to the pharmaceutical industry, where the quality precision of the product is of utmost importance. Our focus on the cosmetics industry is driven by the need to deliver quality emulsions and suspensions that meet consumers’ preferences and regulatory compliance.

Understanding Semi-Solid Manufacturing Plant

Semi-solid dosage forms refer to a type of medication with a consistency that falls somewhere between a liquid and a solid. They are also known as quasi-solid and are characterized by their high viscosity, which gives them a slightly flexible nature. This category of medication includes various forms such as ointments, pastes, creams, gels, rigid foams, and suppositories. These semi-solid forms can be available in two forms- 

• Conventional Semi-Solid Dosage Forms 
• Novel Semi-Solid Dosage Forms

Implementation & Benefits

• Topical applications have a lower risk of side effects compared to other types of medication as they are applied directly to the affected area.
• These applications have a specific action site, making it easier to focus treatment where needed.
• Topical treatments can be more convenient for patients with difficulty taking oral medications.
• Semi-solid dosage forms used in topical treatments avoid hepatic metabolism.
• Topical applications have a higher stability than liquids.
• The goopy nature of semi-solid dosage forms makes them easier to apply to the skin.
• Topical applications can be used for a variety of purposes, including therapeutic, cosmetic, or protective functions.

Conclusion

The manufacturing and scaling of semi-solid doses can be a complicated process, but having the proper equipment and an experienced team can make all the difference. This is where LGM enters the picture. With our recent acquisition of NextGen, we can now offer our clients the highest level of semi-solid dose manufacturing expertise, paired with state-of-the-art equipment. Our experienced team has been tackling semi-solid dose production challenges for decades, from high volumes of blue star ointment in the 2000s to limited extraction of pseudoephedrine products. Our personalized service, with our unique fee-for-service and partnership/risk-profit-sharing model, applies to every customer, ensuring they receive customized solutions. The demand for semi-solid doses is increasing, and as the global population ages and companies continue to innovate, the market for semi-solid doses will continue to evolve. We at LGM will be here to meet these challenges.